These benefits, along with a past report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a unique strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated disorders. These benefits suggest that conolidine is https://conolidine-is-not-an-opio35566.blogrelation.com/38596877/top-latest-five-conolidine-urban-news